ES2634613T3 - Métodos de obtención de leche estéril y composiciones de la misma - Google Patents
Métodos de obtención de leche estéril y composiciones de la misma Download PDFInfo
- Publication number
- ES2634613T3 ES2634613T3 ES07811645.6T ES07811645T ES2634613T3 ES 2634613 T3 ES2634613 T3 ES 2634613T3 ES 07811645 T ES07811645 T ES 07811645T ES 2634613 T3 ES2634613 T3 ES 2634613T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- fraction
- milk
- whole milk
- skimmed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract 15
- 239000000203 mixture Substances 0.000 title claims abstract 7
- 239000008267 milk Substances 0.000 title 1
- 210000004080 milk Anatomy 0.000 title 1
- 235000013336 milk Nutrition 0.000 title 1
- 235000008939 whole milk Nutrition 0.000 claims abstract 9
- 102000004169 proteins and genes Human genes 0.000 claims abstract 8
- 108090000623 proteins and genes Proteins 0.000 claims abstract 8
- 230000000717 retained effect Effects 0.000 claims abstract 8
- 235000020256 human milk Nutrition 0.000 claims abstract 6
- 210000004251 human milk Anatomy 0.000 claims abstract 6
- 238000001914 filtration Methods 0.000 claims abstract 5
- 238000000108 ultra-filtration Methods 0.000 claims abstract 4
- 238000010438 heat treatment Methods 0.000 claims abstract 3
- 238000000926 separation method Methods 0.000 claims abstract 2
- 239000000470 constituent Substances 0.000 claims 3
- 240000001817 Cereus hexagonus Species 0.000 claims 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 235000020200 pasteurised milk Nutrition 0.000 claims 1
- 238000009928 pasteurization Methods 0.000 claims 1
- 239000012466 permeate Substances 0.000 claims 1
- 235000020183 skimmed milk Nutrition 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 208000006379 syphilis Diseases 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
- A23C9/206—Colostrum; Human milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B11/00—Preservation of milk or dairy products
- A23B11/10—Preservation of milk or milk preparations
- A23B11/12—Preservation of milk or milk preparations by heating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
- A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
- A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/25—Separating and blending
- A23C2210/252—Separating a milk product in at least two fractions followed by treatment of at least one of the fractions and remixing at least part of the two fractions
Landscapes
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Water Supply & Treatment (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Un método para la obtención de una composición de leche humana que comprende: (a) filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros; (b) tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes; (c) separación de la leche entera en una porción desnatada y una porción de grasa; (d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y una fracción retenida desnatada rica en proteínas; (e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana.
Description
12
Claims (11)
- REIVINDICACIONES1. Un método para la obtención de una composición de leche humanaque comprende: 5
- (a)
- filtración de leche entera agrupada a través de un filtro de 100-400 micrómetros;
- (b)
- tratamiento térmico de la leche entera a 58-65 °C durante 20-40 minutes;
- (c)
- separación de la leche entera en una porción desnatada y una porción de grasa;
(d) ultrafiltración de la porción desnatada a través de uno o más ultrafiltros para obtener una porción permeada y 10 una fracción retenida desnatada rica en proteínas;(e) mezclado de una fracción de la porción de grasa con la fracción retenida desnatada rica en proteínas para obtener una composición de leche humana. - 2. El método de la reivindicación 1, que comprende además el análisis de una muestra de la leche entera para 15 determinar la presencia de VIH1, VIH2, VHB, VHC, HTLVI, HTLVII, sífilis y B. cereus antes de la filtración.
- 3. El método de la reivindicación 1, en el que el filtrado de la leche entera en la etapa (a) se realiza a través de un tamiz de filtro de 200 micrómetros.20 4. El método de la reivindicación 1, en el que el tratamiento térmico de la leche entera en la etapa (b) se realiza a 63 °C durante 30 minutos.
- 5. El método de la reivindicación 1 en el que la porción de grasa obtenida en la etapa (c) se sigue procesando paraobtener una porción de leche desnatada adicional. 25
- 6. El método de la reivindicación 5, en el que la porción desnatada adicional se agrupa con la porción desnatada obtenida en la etapa (c).
- 7. El método de la reivindicación 1, que comprende además recoger y filtrar la fracción permeada obtenida en la 30 etapa (d) para obtener una segunda fracción retenida.
- 8. El método de la reivindicación 7 en el que la segunda fracción retenida se añade a la primera fracción retenida obtenida en la etapa (d) de la reivindicación 1.35 9. El método de la reivindicación 1 en el que la ultrafiltración utiliza una membrana de ultrafiltración que impide el paso de cualquier sustancia con un peso molecular superior a 1-40 kDa.
- 10. El método de las reivindicaciones 1 o 7 que comprende además el lavado de los ultrafiltros con la fracciónpermeada obtenida en la etapa (d) de la reivindicación 1 para obtener un lavado de proteína y la adición del lavado 40 de proteína a la fracción retenida desnatada rica en proteína obtenida en la etapa (d).
- 11. El método de la reivindicación 1 en el que tras la pasteurización, se analiza la leche pasteurizada para determinar el contenido nutricional, el contenido de proteínas, los factores específicos y se ajusta a un nivel deseado.45
- 12. El método de la reivindicación 1, en el que se pasteuriza la composición de leche humana obtenida en la etapa (e).
- 13. Una composición de leche humana obtenida según el método de una cualquiera de las reivindicaciones 50 anteriores que comprende:
- (a)
- un constituyente de proteína de 20-70 mg/ml;
- (b)
- un constituyente de grasa de 35-85 mg/ml,
(c) un constituyente de hidratos de carbono de 70-115 mg/ml. 5516
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84137106P | 2006-08-30 | 2006-08-30 | |
| US841371P | 2006-08-30 | ||
| US86774806P | 2006-11-29 | 2006-11-29 | |
| US867748P | 2006-11-29 | ||
| PCT/US2007/019234 WO2008027572A1 (en) | 2006-08-30 | 2007-08-30 | Methods of obtaining sterile milk and compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2634613T3 true ES2634613T3 (es) | 2017-09-28 |
Family
ID=39136247
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES07811645.6T Active ES2634613T3 (es) | 2006-08-30 | 2007-08-30 | Métodos de obtención de leche estéril y composiciones de la misma |
Country Status (6)
| Country | Link |
|---|---|
| US (8) | US9149052B2 (es) |
| EP (1) | EP2063722B1 (es) |
| JP (2) | JP5448819B2 (es) |
| ES (1) | ES2634613T3 (es) |
| PT (1) | PT2099321T (es) |
| WO (1) | WO2008027572A1 (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020182243A1 (en) | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| WO2007035870A2 (en) | 2005-09-20 | 2007-03-29 | Prolacta Bioscience, Inc. | A method for testing milk |
| DK3485742T3 (da) | 2006-11-29 | 2021-11-15 | Prolacta Bioscience Inc | Modermælkssammensætninger og fremgangsmåder til fremstilling og anvendelse deraf |
| US8377445B2 (en) | 2006-12-08 | 2013-02-19 | Prolacta Bioscience, Inc. | Compositions of human lipids and methods of making and using same |
| CN102300575A (zh) * | 2008-12-02 | 2011-12-28 | 普罗莱克塔生物科学公司 | 人乳渗透物组合物及其制备和使用方法 |
| DK2739157T3 (en) | 2011-08-03 | 2018-01-08 | Prolacta Bioscience Inc | Microfiltration of human milk to reduce bacterial contamination |
| US9781947B2 (en) * | 2011-10-18 | 2017-10-10 | Nestec S.A. | Composition for use in the promotion of magnesium absorption and/or magnesium retention |
| US9458230B2 (en) * | 2013-01-04 | 2016-10-04 | Wisconsin Alumni Research Foundation | Secretory IGA compositions, methods of making and methods of use thereof |
| CN105246342A (zh) | 2013-03-13 | 2016-01-13 | 普罗莱克塔生物科学公司 | 高脂人乳产品 |
| US20140271980A1 (en) * | 2013-03-13 | 2014-09-18 | Prolacta Bioscience | Adulteration testing of human milk |
| ITMI20131690A1 (it) * | 2013-10-14 | 2015-04-15 | Consiglio Nazionale Ricerche | Composizione alimentare. |
| AU2015374053B2 (en) * | 2014-12-30 | 2020-04-09 | Prolacta Bioscience, Inc. | Methods of preventing and treating bronchopulmonary dysplasia using high fat human milk products |
| SG11201805635RA (en) | 2015-12-30 | 2018-07-30 | Prolacta Bioscience Inc | Human milk products useful in pre- and post-operative care |
| JP7458187B2 (ja) * | 2016-10-04 | 2024-03-29 | ラクタロジックス, インコーポレイテッド | 滅菌人乳製品を生成するための方法およびシステム |
| WO2020123121A1 (en) * | 2018-12-11 | 2020-06-18 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Methods of screening antibodies for treating and/or preventing necrotizing enterocolitis (nec) |
| US20230248011A1 (en) * | 2019-02-07 | 2023-08-10 | Saurin Enterprises PL | Human milk fortifier |
| EP3927171A4 (en) | 2019-02-22 | 2022-11-30 | Aquero Canada Ltd. | ENRICHED MILK COMPOSITIONS AND METHODS FOR PREPARING THEM |
| BR112022005578A2 (pt) | 2019-09-24 | 2022-09-20 | Prolacta Bioscience Inc | Composições e métodos para tratamento de doenças inflamatórias e imunes |
| WO2022148549A1 (en) | 2020-01-14 | 2022-07-14 | Babylat Gmbh | Apparatus and method for obtaining protein-enriched fractions from breast milk |
| WO2021146561A1 (en) | 2020-01-17 | 2021-07-22 | Prolacta Bioscience, Inc. | Feeding protocol for optimal growth of preterm infants |
| CN116322371A (zh) | 2020-08-14 | 2023-06-23 | 普罗莱克塔生物科学公司 | 与细菌疗法一起使用的人乳寡糖组合物 |
| MX2023008227A (es) | 2021-01-12 | 2023-07-20 | Prolacta Bioscience Inc | Regimenes de tratamiento simbiotico. |
| AU2022211396A1 (en) | 2021-01-22 | 2023-06-29 | Prolacta Bioscience, Inc. | Topical human milk formulations |
| WO2024130119A2 (en) | 2022-12-16 | 2024-06-20 | Prolacta Bioscience, Inc. | Synbiotic compositions for short chain fatty acid production |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2148100A (en) * | 1936-07-01 | 1939-02-21 | M & R Dietetic Lab Inc | Treatment of milk fluids |
| JPS5948964B2 (ja) * | 1978-01-11 | 1984-11-30 | 雪印乳業株式会社 | 人乳に類似した育児用乳の製造法 |
| JPS6133895Y2 (es) * | 1980-02-29 | 1986-10-03 | ||
| US4462932A (en) * | 1983-06-22 | 1984-07-31 | Purdue Research Foundation | Isolation of native casein by cryodestabilization |
| JPS6467141A (en) * | 1987-09-08 | 1989-03-13 | Kougakushiya Kk | Method for removing various germs and somatic cell from cow's milk and apparatus therefor |
| JP3061649B2 (ja) * | 1991-02-08 | 2000-07-10 | 森永乳業株式会社 | 抗アレルギー性調製乳 |
| WO1993020717A2 (en) * | 1992-04-13 | 1993-10-28 | Research Corporation Technologies, Inc. | Reducing gastrointestinal irritation in infant nutrition |
| JP3150504B2 (ja) * | 1993-02-26 | 2001-03-26 | 雪印乳業株式会社 | 低乳糖乳製品およびその製造方法 |
| DE4424935C1 (de) * | 1994-07-14 | 1996-03-21 | Immuno Ag | Humanes virussicheres monomeres Immunglobulin A und Verfahren zu seiner Herstellung |
| US5670196A (en) * | 1995-04-12 | 1997-09-23 | Galagen Inc. | Method for microfiltration of milk or colostral whey |
| JPH09275897A (ja) * | 1996-04-16 | 1997-10-28 | Takamichi Tominaga | ミルクの調整法及び粉ミルク計量器及び粉ミルク計量器の組合せ |
| US6194009B1 (en) * | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
| US6652900B2 (en) * | 1997-03-14 | 2003-11-25 | Tetra Laval Holdings & Finance S.A. | Method and plant for producing a sterile milk product |
| NL1010829C2 (nl) * | 1998-12-16 | 2000-06-19 | Prolion Bv | Inrichting en werkwijze voor het melken van dieren en een vervuilingsmeter. |
| US6294206B1 (en) * | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
| EP1233976A4 (en) * | 1999-11-17 | 2003-06-11 | Jiuping Ji | SIMULTANEOUS DETECTION OF HBV, HCV AND HIV IN PLASMA SAMPLES WITH THE AID OF A MULTIPLEX FIXING TEST |
| US6932967B2 (en) * | 2001-03-22 | 2005-08-23 | Michael R. Simon | Human medical treatment by aerosol inhalation of immunoglobulin A |
| AU2002311897A1 (en) * | 2001-05-09 | 2002-11-18 | Third Wave Technologies, Inc. | Nucleic acid detection in pooled samples |
| US20020182243A1 (en) * | 2001-05-14 | 2002-12-05 | Medo Elena Maria | Method of producing nutritional products from human milk tissue and compositions thereof |
| PT1474003E (pt) * | 2002-02-04 | 2008-02-29 | Bristol Myers Squibb Co | Suplemento para leite humano |
| FI115752B (fi) * | 2002-05-14 | 2005-07-15 | Valio Oy | Menetelmä käytettäväksi vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi |
| NZ527434A (en) * | 2003-08-07 | 2006-03-31 | Fonterra Co Operative Group | Production of protein composition from a dairy stream and its use as an ingredient in the manufacture of a cheese |
| JP2008512656A (ja) * | 2004-09-10 | 2008-04-24 | メデラ ホールディング アーゲー | 人乳の分析及び処理方法とそのためのシステム |
| EP1637043A1 (en) * | 2004-09-17 | 2006-03-22 | Medela Holding AG | Human milk fortifiers and methods for their production |
| US20080187619A1 (en) * | 2004-09-10 | 2008-08-07 | Medela Holding Ag | Human Milk Fortifiers and Methods for Their Production |
-
2007
- 2007-08-30 WO PCT/US2007/019234 patent/WO2008027572A1/en not_active Ceased
- 2007-08-30 EP EP07811645.6A patent/EP2063722B1/en active Active
- 2007-08-30 ES ES07811645.6T patent/ES2634613T3/es active Active
- 2007-08-30 US US12/438,789 patent/US9149052B2/en active Active
- 2007-08-30 JP JP2009526751A patent/JP5448819B2/ja active Active
- 2007-11-29 PT PT78649217T patent/PT2099321T/pt unknown
-
2012
- 2012-07-23 JP JP2012162801A patent/JP5770690B2/ja active Active
-
2015
- 2015-08-21 US US14/832,920 patent/US20160050949A1/en not_active Abandoned
-
2017
- 2017-06-21 US US15/629,278 patent/US20170347675A1/en not_active Abandoned
-
2018
- 2018-10-24 US US16/169,204 patent/US20190053508A1/en not_active Abandoned
- 2018-11-14 US US16/191,129 patent/US20190075809A1/en not_active Abandoned
-
2019
- 2019-07-08 US US16/504,994 patent/US20190327994A1/en not_active Abandoned
-
2022
- 2022-04-12 US US17/719,098 patent/US20220232844A1/en not_active Abandoned
-
2024
- 2024-08-13 US US18/802,726 patent/US20250185679A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT2099321T (pt) | 2017-07-21 |
| EP2063722A4 (en) | 2011-05-18 |
| WO2008027572A1 (en) | 2008-03-06 |
| US20190075809A1 (en) | 2019-03-14 |
| US20190327994A1 (en) | 2019-10-31 |
| JP5448819B2 (ja) | 2014-03-19 |
| US20190053508A1 (en) | 2019-02-21 |
| US20160050949A1 (en) | 2016-02-25 |
| US9149052B2 (en) | 2015-10-06 |
| JP2012231793A (ja) | 2012-11-29 |
| US20220232844A1 (en) | 2022-07-28 |
| EP2063722A1 (en) | 2009-06-03 |
| EP2063722B1 (en) | 2017-05-03 |
| US20250185679A1 (en) | 2025-06-12 |
| JP5770690B2 (ja) | 2015-08-26 |
| JP2010502186A (ja) | 2010-01-28 |
| US20110256269A1 (en) | 2011-10-20 |
| US20170347675A1 (en) | 2017-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2634613T3 (es) | Métodos de obtención de leche estéril y composiciones de la misma | |
| Giangrande | Six characters in search of an author: the history of the nomenclature of coagulation factors. | |
| Burt et al. | Does low birthweight increase the risk of caries? A systematic review | |
| ES2529567T3 (es) | Procedimiento de fraccionamiento de composiciones lácteas | |
| ES2234552T3 (es) | Un metodo para tratamiento de calostro. | |
| EP2972312A1 (en) | Adulteration testing of human milk | |
| Emektar et al. | Determination of factors associated with perforation in patients with geriatric acute appendicitis | |
| Garrido-Castañé et al. | Cardiopulmonary helminths in foxes from the Pyrenees | |
| Kara et al. | Various clinical conditions can mimic Crimean-Congo hemorrhagic fever in pediatric patients in endemic regions | |
| Prasongwatana et al. | Chemical components of urinary stones according to age and sex of adult patients | |
| US10694768B2 (en) | Process for preparing a soluble protein composition | |
| Mahmud et al. | Anemia characteristics after renal transplantation | |
| Salim et al. | Oral findings, salivary creatinine and urea levels in CKD patients on hemodialysis and on conservative treatment | |
| Karjoo et al. | Review of natural history, benefits and risk factors pediatric liver transplantation | |
| Porter | Remarks on intestinal parasites in Montreal, and the relation of Entamoeba histolytica to colitis | |
| Stoiber et al. | Whole blood, plasma viscosity, and erythrocyte aggregation as a determining factor of competitiveness in standard bred trotters | |
| Calabrese et al. | Review and practical excursus of the propensity score: low protein diet compared to Mediterranean diet in patients with chronic kidney disease | |
| Jorfizadeh et al. | Relationships of Students’ Mental Well-being with Mothers’ Emotional Breakdown and Marital Justice Mediated by Mothers’ Marital Intimacy | |
| Martha et al. | A Prospective Study of Clinical Profile in Febrile Illness with Thrombocytopenia in Children Aged 1 to 12 Years Admitted in a Tertiary Care Centre in Telangana | |
| Souto et al. | Arteritis, aneurysm and thromboembolic colic caused by migration of Strongylus vulgaris larvae in equids | |
| Sangani et al. | Prevalence of Intestinal Parasites in a Tertiary Care Hospital in Rural Areas of Dahod. | |
| Ghasemikhah et al. | Echinococcosis in livestock slaughtered in arak industrial abattoir in Central Iran during 2006 to 2012 | |
| Al-Hajjaj | Massive pulmonary hemorrhage in a Saudi female with primary antiphospholipid syndrome | |
| Saeed et al. | Cysticercus bovis induced hemato-biochemical changes in cattle and buffaloes. | |
| Krautzig et al. | Bacterial challenge of NISSHO ultrafilter ETF 609: Results of in vitro testing |